Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment - 21/08/11
Summary |
Chondrosarcoma is a malignant cartilage-forming tumour of bone, of which distinct clinicopathological subtypes are known. Conventional chondrosarcoma is notorious for its locally aggressive behaviour as well as for its resistance to chemotherapy and radiotherapy; so far surgery is the only effective therapeutic option. During the past 10 years, substantial new insights have been gained about molecular cell biology, molecular cytogenetics, and immunopathology, leading to better understanding of chondrosarcoma development at the molecular level, which will ultimately lead to better clinical understanding and possibly to the development of targeted treatment.
Le texte complet de cet article est disponible en PDF.Plan
Vol 6 - N° 8
P. 599-607 - août 2005 Retour au numéro
Article précédent
- Clinical potential of inhibitors of survival pathways and activators of apoptotic pathways in treatment of cervical cancer: changing the apoptotic balance
- Brigitte MT Hougardy, John H Maduro, Ate GJ van der Zee, Pax HB Willemse, Steven de Jong, Elisabeth GE de Vries
- Follow-up in patients with localised primary cutaneous melanoma
- Anne Brecht Francken, Esther Bastiaannet, Harald J Hoekstra
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?